The AF was pretreated with Verteporfin (1 μM) for 24 h, followed by incubated with TGF‐β (10 ng/mL) for 24 h; we found that AF transformation and migration were significantly inhibited by Verteporfin (Figure 5A,B). Here, TGFB1 is linked to atrial fibrillation.